Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Jason Celino Raises Price Target and Maintains Overweight Rating on Procore Technologies

Elaine Mendonca by Elaine Mendonca
January 12, 2024
in Breaking News
0
Biotechnology Markets and money
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

On January 12, 2024, Jason Celino, an esteemed analyst at Keybanc, expressed his positive sentiments towards Procore Technologies (NYSE: PCOR). In his evaluation, Celino not only maintained an Overweight rating on the company but also raised the price target from $70 to $77, indicating a strong belief in its stock performance. The Overweight rating signifies Celino’s expectation that Procore Technologies will surpass the average returns of other stocks analyzed by his research team. This revised price target serves as a testament to Celino’s unwavering confidence in the company’s promising future prospects.

PCOR Stock Analysis: Factors Behind the Slight Decline on January 12, 2024

On January 12, 2024, PCOR stock closed at $68.85, experiencing a decrease of $0.85 or 1.22% since the market last closed. Trading near the top of its 52-week range and above its 200-day simple moving average suggests positive performance over the past year and an overall upward trend. However, the price change on January 12 indicates a slight decline, potentially due to various factors. After-hours trading saw an additional drop of $0.59, possibly indicating continued selling pressure. It is important for investors to conduct thorough research and analysis before making any investment decisions.

PCOR Stock Performance: Strong Revenue Growth but Challenges in Net Income

PCOR Stock Performance on January 12, 2024: A Look at the Numbers

Total revenue for PCOR stood at $720.20 million in the past year, representing a significant increase of 39.89% compared to the previous year. Additionally, the company’s total revenue increased by 8.48% since the last quarter, reaching $247.91 million.

However, the net income figures present a slightly different picture. PCOR reported a net loss of -$286.93 million in the past year, marking a decrease of 8.21% compared to the previous year. However, there was a positive development in the most recent quarter, as the net loss decreased by 17.08% to -$43.85 million.

The earnings per share (EPS) figures also provide insights into PCOR’s financial performance. Over the past year, the company reported an EPS of -$2.10, which represents a decrease of 6.24% compared to the previous year. However, in the most recent quarter, the EPS increased by 18.0% to -$0.31.

Analyzing these numbers, it is clear that PCOR has experienced significant growth in its total revenue over the past year, with a notable increase in the most recent quarter. However, the company still faces challenges in terms of net income, as it reported losses in both the past year and the most recent quarter. Despite these losses, there has been a reduction in net losses in the most recent quarter, indicating a potential turnaround in the future.

Investors and stakeholders should closely monitor PCOR’s financial performance in the coming quarters to assess if the positive trends in total revenue and EPS continue while the company works towards achieving profitability. It is important to note that these figures provide only a snapshot of PCOR’s performance on January 12, 2024, and further analysis is required to fully understand the company’s financial health and growth prospects.

Tags: PCOR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
SNDR stock news

BlackRock Reports Impressive Financial Results and Strategic Acquisitions in 2023

Technology Data analytics Stock Exchange

TechTarget Stock Analysis Diverse Perspectives and Volatility

MMM stock news

Analyst Ratings and Price Targets for Fleetcor Technologies

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com